Table 2.
CHUM (Selective TATT) N = 69 |
CHUS (Ticagrelor-DAPT) N = 108 |
Unadjusted p-value | |
---|---|---|---|
MACCE | 7 (10%) | 21 (19%) | 0.139 |
Death | 3 (4%) | 7 (6%) | 0.742 |
Myocardial Infarction | 1 (1%) | 0 (0%) | 0.390 |
Unplanned Revascularization | 2 (3%) | 15 (14%) | 0.018* |
TLR | 0 (0%) | 5 (5%) | 0.158 |
Non-TLR | 2 (3%) | 10 (9%) | 0.131 |
Stroke/TIA | 1 (1%) | 0 (0%) | 0.390 |
Major Bleeding | 4 (6%) | 0 (0%) | 0.022* |
In-Hospital Transfusion | 4 (6%) | 1 (1%) | 0.074 |
LVT* | 0 (0%) | 0 (0%) | — |
MACCE: Major adverse cardiovascular and cerebrovascular event. TLR: Target lesion revascularization. LVT: Left ventricular thrombus.
*LVT was an exclusion criterion for this analysis.